Anis, N.A., et al., The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmaco, 1983. 79(2) : 565-75.

Newcomer, J.W., et al., Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology, 1999. 20(2 ): 106-18.

Krystal, J.H., et al., Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry, 1994. 51(3) : 199-214.

Fletcher, P.C. and C.D. Frith, Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia. Nat Rev Neurosci, 2009. 10(1) : 48-58.

Corlett, P.R., et al., Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. Arch Gen Psychiatry, 2006. 63(6) : 611-21.

Corlett, P.R., G.D. Honey, and P.C. Fletcher, From prediction error to psychosis: ketamine as a pharmacological model of delusions. J Psychopharmacol, 2007. 21(3 ):238-52.

Carlsson, A., et al., Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol, 2001. 41: 237-60.

Kegeles, L.S., et al., Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry, 2000. 48(7) : 627-40.

Moghaddam, B., et al., Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci, 1997. 17(8) : 2921-7.

Tsapakis, E.M. and M.J. Travis, Glutamate and psychiatric disorders. Advances in Psychiatric Treatments, 2002. 8 : 189-197.

Tsai, G., et al., Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia. Biol Psychiatry, 1998. 44(8) : 667-74.

Tsai, G., et al., D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry, 1998. 44(11) : 1081-9.

Goff, D.C., et al., A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry, 1999. 56(1) : 21-7.

Heresco-Levy, U., et al., Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry, 1999. 56(1) : 29-36.

Moghaddam, B. and B.W. Adams, Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science, 1998. 281(5381) : 1349-52.

Anand, A., et al., Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry, 2000. 57(3) : 270-6.

Olney, J.W., D.F. Wozniak, and N.B. Farber, Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies. Arch Neurol, 1997. 54(10) : 1234-40.

Bechara, A., et al., Double dissociation of conditioning and declarative knowledge relative to the amygdala and hippocampus in humans. Science, 1995. 269(5227) : 1115-8.

Furmak, T., et al., The amygdala and individual differences in human fear conditionning. Neuroreport, 1997. 8 : 3957-3960.

LaBar, K.S., et al., Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron, 1998. 20(5) : 937-45.

Büchel, C., et al., Brain systems mediating aversive conditionning : an event-related fonctional magnetic resonance imaging. Neuron, 1998. 20 : 947-957.

Büchel, C., et al., Amygdala-hippocampal involvement in human aversive trace conditionning revealed through event-related functional magnetic resonance imaging. J Neurosci, 1999. 19 : 10869-10876.

Myers, K.M., K.J. Ressler, and M. Davis, Different mechanisms of fear extinction dependent on length of time since fear acquisition. Learn Mem, 2006. 13(2) : 216-23.

Myers, K.M. and M. Davis, Behavioral and neural analysis of extinction. Neuron, 2002. 36(4) : 567-84.

Falls, W.A., M.J. Miserendino, and M. Davis, Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci, 1992.12(3) : 854-63.

Walker, D.L., et al., Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fearpotentiated startle in rats. J Neurosci, 2002. 22(6) : 2343-51.

Ledgerwood, L., R. Richardson, and J. Cranney, D-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol Psychiatry, 2005. 57(8) : 841-7.

Ohman, A. and S. Mineka, Fears, phobias, and preparedness: toward an evolved module of fear and fear learning. Psychol Rev, 2001. 108(3) : 483-522.

Straube, T., et al., Effects of cognitive-behavioral therapy on brain activation in specific phobia. Neuroimage, 2006. 29(1) : 125-35.

Ressler, K.J., et al., Cognitive enhancers as adjuncts to psychotherapy: use of Dcycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry, 2004. 61(11) : 1136-44.

Hofmann, S.G., et al., Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry, 2006. 63(3) : 298-304.

Ostroff, R., M. Gonzales, and G. Sanacora, Antidepressant effect of ketamine during ECT. Am J Psychiatry, 2005. 162(7) : 1385-6.

Berman, R.M., et al., Antidepressant effects of ketamine in depressed patients. Biol Psychiatry, 2000. 47(4) : 351-4.

Zarate, C.A., Jr., et al., A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry, 2006. 63(8) : 856-64.

Zarate, C.A., Jr. in Meeting of the Society of Biological Psychiatry. 2009. Vancouver.

McEwen, B.S. and J.P. Olie, Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine. Mol Psychiatry, 2005. 10(6) : 525-37.

Rocher, C., et al., Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cereb Cortex, 2004. 14(2 ): 224-9.